SFRP4 and cancer: sFRP4 can sequester Wnt ligands within stroma to abrogate canonical Wnt signalling flux, and also act as a gatekeeper, and thus affect epithelial–mesenchymal transition (EMT), apoptosis, and invasion within cancer cells 26, 27.